Chronic myelogenous leukemia.
Publication
, Journal Article
O'Brien, S; Berman, E; Bhalla, K; Copelan, EA; Devetten, MP; Emanuel, PD; Erba, HP; Greenberg, PL; Moore, JO; Przepiorka, D; Radich, JP ...
Published in: J Natl Compr Canc Netw
November 2005
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
ISSN
1540-1405
Publication Date
November 2005
Volume
3
Issue
6
Start / End Page
732 / 755
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Translocation, Genetic
- Secondary Prevention
- Remission Induction
- Recombinant Fusion Proteins
- Pyrimidines
- Practice Guidelines as Topic
- Piperazines
- Oncology & Carcinogenesis
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Brien, S., Berman, E., Bhalla, K., Copelan, E. A., Devetten, M. P., Emanuel, P. D., … Wetzler, M. (2005). Chronic myelogenous leukemia. J Natl Compr Canc Netw, 3(6), 732–755. https://doi.org/10.6004/jnccn.2005.0044
O’Brien, Susan, Ellin Berman, Kapil Bhalla, Edward A. Copelan, Marcel P. Devetten, Peter D. Emanuel, Harry P. Erba, et al. “Chronic myelogenous leukemia.” J Natl Compr Canc Netw 3, no. 6 (November 2005): 732–55. https://doi.org/10.6004/jnccn.2005.0044.
O’Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, et al. Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2005 Nov;3(6):732–55.
O’Brien, Susan, et al. “Chronic myelogenous leukemia.” J Natl Compr Canc Netw, vol. 3, no. 6, Nov. 2005, pp. 732–55. Pubmed, doi:10.6004/jnccn.2005.0044.
O’Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, Erba HP, Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M. Chronic myelogenous leukemia. J Natl Compr Canc Netw. 2005 Nov;3(6):732–755.
Published In
J Natl Compr Canc Netw
DOI
ISSN
1540-1405
Publication Date
November 2005
Volume
3
Issue
6
Start / End Page
732 / 755
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Translocation, Genetic
- Secondary Prevention
- Remission Induction
- Recombinant Fusion Proteins
- Pyrimidines
- Practice Guidelines as Topic
- Piperazines
- Oncology & Carcinogenesis
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive